Hypertension among adults aged 30-79 years, prevalence in Low income (World Bank)
Low income (World Bank): Hypertension among adults aged 30-79 years, prevalence was 34.2 in 2019. ▲ Rising
Hypertension among adults aged 30-79 years, prevalence in Low income (World Bank), 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension among adults aged 30-79 years, prevalence in Low income (World Bank) stood at 34.2.
Compared with earlier readings it is down 0.6% on the previous year and down 3.4% over ten years.
Over the whole period, hypertension among adults aged 30-79 years, prevalence in Low income (World Bank) peaked at 35.4 in 2008 and was at its lowest, 33.2, in 1990.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension among adults aged 30-79 years, prevalence in Low income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 33.2 | — |
| 1991 | 33.3 | +0.3% |
| 1992 | 33.3 | +0.0% |
| 1993 | 33.4 | +0.3% |
| 1994 | 33.4 | +0.0% |
| 1995 | 33.5 | +0.3% |
| 1996 | 33.6 | +0.3% |
| 1997 | 33.6 | +0.0% |
| 1998 | 33.8 | +0.6% |
| 1999 | 33.9 | +0.3% |
| 2000 | 34 | +0.3% |
| 2001 | 34.2 | +0.6% |
| 2002 | 34.4 | +0.6% |
| 2003 | 34.6 | +0.6% |
| 2004 | 34.8 | +0.6% |
| 2005 | 35 | +0.6% |
| 2006 | 35.1 | +0.3% |
| 2007 | 35.3 | +0.6% |
| 2008 | 35.4 | +0.3% |
| 2009 | 35.4 | +0.0% |
| 2010 | 35.4 | +0.0% |
| 2011 | 35.3 | -0.3% |
| 2012 | 35.2 | -0.3% |
| 2013 | 35.1 | -0.3% |
| 2014 | 35 | -0.3% |
| 2015 | 34.8 | -0.6% |
| 2016 | 34.7 | -0.3% |
| 2017 | 34.5 | -0.6% |
| 2018 | 34.4 | -0.3% |
| 2019 | 34.2 | -0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 33.5 | 33.2 | 33.9 | 10 |
| 2000s | 34.82 | 34 | 35.4 | 10 |
| 2010s | 34.86 | 34.2 | 35.4 | 10 |
Countries ranked near Low income (World Bank)
More health data for Low income (World Bank)
- Measles - number of reported cases, gaps filled 197,977 (2025)
- Diphtheria - number of reported cases, gaps filled 7,814 (2025)
- Total tetanus - number of reported cases, gaps filled 5,130 (2025)
- Pertussis - number of reported cases, gaps filled 16,008 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1,406 (2025)
- Number of under-five deaths, annual growth rate -0.6182 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate 0.2365 % change on previous year (2024)
- Number of infant deaths, annual growth rate -0.222 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 6.99 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 289.49 % change on previous year (2025)
Frequently asked questions
- What is hypertension among adults aged 30-79 years, prevalence in Low income (World Bank)?
- Hypertension among adults aged 30-79 years, prevalence in Low income (World Bank) was 34.2 in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension among adults aged 30-79 years, prevalence recorded in Low income (World Bank)?
- The highest recorded value was 35.4 in 2008.
- What is the lowest hypertension among adults aged 30-79 years, prevalence recorded in Low income (World Bank)?
- The lowest recorded value was 33.2 in 1990.
- How does Low income (World Bank) rank for hypertension among adults aged 30-79 years, prevalence?
- Low income (World Bank) ranks 5th out of 11 groups with data for 2019.
- Is hypertension among adults aged 30-79 years, prevalence rising or falling in Low income (World Bank)?
- Over the last ten years it is down 3.4%. The long-run trend across the full record is rising.
- Where does this Low income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension among adults aged 30-79 years, prevalence, age-standardized. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).